Relation of Adiponectin and High-Sensitivity C-Reactive Protein to Pulse-Wave Velocity and N-Terminal Pro-B-Type Natriuretic Peptide in the General Population

American Journal of Cardiology

Volumn 103, Issue 10, 2009, Pages 1411-1416

  Sung, Shih Hsien ^a   Chuang, Shao Yuan ^c   Sheu, Wayne Huey Herng ^d   Lee, Wen Jane ^d   Chou, Pesus ^b   Chen, Chen Huan ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^d TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER; C REACTIVE PROTEIN; HIGH SENSITIVITY C REACTIVE PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTERIAL STIFFNESS; ARTICLE; BODY MASS; BRACHIAL ANKLE PULSE WAVE VELOCITY; CHINESE; DISEASE ASSOCIATION; FEMALE; GENDER; HEALTH SURVEY; HEART VENTRICLE FUNCTION; HUMAN; INFLAMMATION; KIDNEY FUNCTION; MALE; METABOLIC SYNDROME X; NORMAL HUMAN; POPULATION; PRIORITY JOURNAL; PULSE WAVE;

ADIPONECTIN; ADULT; AGED; AGED, 80 AND OVER; ANTHROPOMETRY; BIOLOGICAL MARKERS; BLOOD FLOW VELOCITY; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CHINA; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INFLAMMATION; METABOLIC SYNDROME X; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PULSE; QUESTIONNAIRES; RADIOIMMUNOASSAY; RISK ASSESSMENT; RISK FACTORS;

EID: 65449124608     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.01.355     Document Type: Article

References (30)

1. Bahrami H., Bluemke D.A., Kronmal R., Bertoni A.G., Lloyd-Jones D.M., Shahar E., Szklo M., and Lima J.A. Novel metabolic risk factors for incident heart failure and their relationship with obesity: the MESA (Multi-Ethnic Study of Atherosclerosis) study. J Am Coll Cardiol 51 (2008) 1775-1783
2. Brooks N.L., Moore K.S., Clark R.D., Perfetti M.T., Trent C.M., and Combs T.P. Do low levels of circulating adiponectin represent a biomarker or just another risk factor for the metabolic syndrome?. Diabetes Obes Metab 9 (2007) 246-258
3. Hobbs F.D., Davis R.C., Roalfe A.K., Hare R., Davies M.K., and Kenkre J.E. Reliability of N-terminal pro-brain natriuretic peptide assay in diagnosis of heart failure: cohort study in representative and high risk community populations. BMJ 324 (2002) 1498-1502
4. de Lemos J.A., and Hildebrandt P. Amino-terminal pro-B-type natriuretic peptides: testing in general populations. Am J Cardiol 101 (2008) 16-20
5. Chuang S.Y., Chen C.H., Cheng C.M., and Chou P. Combined use of brachial-ankle pulse wave velocity and ankle-brachial index for fast assessment of arteriosclerosis and atherosclerosis in a community. Int J Cardiol 98 (2005) 99-105
6. Yamashina A., Tomiyama H., Takeda K., Tsuda H., Arai T., Hirose K., Koji Y., Hori S., and Yamamoto Y. Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens Res 25 (2002) 359-364
7. Ma Y.C., Zuo L., Chen J.H., Luo Q., Yu X.Q., Li Y., Xu J.S., Huang S.M., Wang L.N., Huang W., et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol 17 (2006) 2937-2944
8. Zieman S.J., Melenovsky V., and Kass D.A. Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler Thromb Vasc Biol 25 (2005) 932-943
9. Tartiere J.M., Logeart D., Safar M.E., and Cohen-Solal A. Interaction between pulse wave velocity, augmentation index, pulse pressure and left ventricular function in chronic heart failure. J Hum Hypertens 20 (2006) 213-219
10. Levy D., Hwang S.J., Kayalar A., Benjamin E.J., Vasan R.S., Parise H., Larson M.G., Wang T.J., Selhub J., Jacques P.F., et al. Associations of plasma natriuretic peptide, adrenomedullin, and homocysteine levels with alterations in arterial stiffness: the Framingham Heart Study. Circulation 115 (2007) 3079-3085
11. Sutton-Tyrrell K., Najjar S.S., Boudreau R.M., Venkitachalam L., Kupelian V., Simonsick E.M., Havlik R., Lakatta E.G., Spurgeon H., Kritchevsky S., et al. Elevated aortic pulse wave velocity, a marker of arterial stiffness, predicts cardiovascular events in well-functioning older adults. Circulation 111 (2005) 3384-3390
12. Olsen M.H., Hansen T.W., Christensen M.K., Gustafsson F., Rasmussen S., Wachtell K., Borch-Johnsen K., Ibsen H., Jorgensen T., and Hildebrandt P. N-Terminal pro brain natriuretic peptide is inversely related to metabolic cardiovascular risk factors and the metabolic syndrome. Hypertension 46 (2005) 660-666
13. Sipila K., Koivistoinen T., Moilanen L., Nieminen T., Reunanen A., Jula A., Salomaa V., Kaaja R., Koobi T., Kukkonen-Harjula K., Majahalme S., and Kahonen M. Metabolic syndrome and arterial stiffness: the Health 2000 Survey. Metabolism 56 (2007) 320-326
14. Safar M.E., Thomas F., Blacher J., Nzietchueng R., Bureau J.M., Pannier B., and Benetos A. Metabolic syndrome and age-related progression of aortic stiffness. J Am Coll Cardiol 47 (2006) 72-75
15. Ferreira I., Boreham C.A., Twisk J.W., Gallagher A.M., Young I.S., Murray L.J., and Stehouwer C.D. Clustering of metabolic syndrome risk factors and arterial stiffness in young adults: the Northern Ireland Young Hearts Project. J Hypertens 25 (2007) 1009-1020
16. Fukui M., Ose H., Kitagawa Y., Kamiuchi K., Nakayama I., Ohta M., Obayashi H., Yamasaki M., Hasegawa G., Yoshikawa T., and Nakamura N. Metabolic syndrome is not associated with markers of subclinical atherosclerosis, serum adiponectin and endogenous androgen concentrations in Japanese men with type 2 diabetes. Diabet Med 24 (2007) 864-871
17. Higashiura K., Ura N., Ohata J., Togashi N., Takagi S., Saitoh S., Murakami H., Takagawa Y., and Shimamoto K. Correlations of adiponectin level with insulin resistance and atherosclerosis in Japanese male populations. Clin Endocrinol (Oxf) 61 (2004) 753-759
18. Nguyen Q.M., Srinivasan S.R., Xu J.H., Chen W., and Berenson G.S. Racial (black-white) divergence in the association between adiponectin and arterial stiffness in asymptomatic young adults: the Bogalusa Heart Study. Am J Hypertens 21 (2008) 553-557
19. Kojima S., Funahashi T., Maruyoshi H., Honda O., Sugiyama S., Kawano H., Soejima H., Miyamoto S., Hokamaki J., Sakamoto T., et al. Levels of the adipocyte-derived plasma protein, adiponectin, have a close relationship with atheroma. Thromb Res 115 (2005) 483-490
20. Tomiyama H., Arai T., Koji Y., Yambe M., Hirayama Y., Yamamoto Y., and Yamashina A. The relationship between high-sensitive C-reactive protein and pulse wave velocity in healthy Japanese men. Atherosclerosis 174 (2004) 373-377
21. Haugen E., Furukawa Y., Isic A., and Fu M. Increased adiponectin level in parallel with increased NT-pro BNP in patients with severe heart failure in the elderly: a hospital cohort study. Int J Cardiol 125 (2008) 216-219
22. von Eynatten M., Hamann A., Twardella D., Nawroth P.P., Brenner H., and Rothenbacher D. Relationship of adiponectin with markers of systemic inflammation, atherogenic dyslipidemia, and heart failure in patients with coronary heart disease. Clin Chem 52 (2006) 853-859
23. Tsioufis C., Dimitriadis K., Selima M., Thomopoulos C., Mihas C., Skiadas I., Tousoulis D., Stefanadis C., and Kallikazaros I. Low-grade inflammation and hypoadiponectinaemia have an additive detrimental effect on aortic stiffness in essential hypertensive patients. Eur Heart J 28 (2007) 1162-1169
24. McEntegart M.B., Awede B., Petrie M.C., Sattar N., Dunn F.G., MacFarlane N.G., and McMurray J.J. Increase in serum adiponectin concentration in patients with heart failure and cachexia: relationship with leptin, other cytokines, and B-type natriuretic peptide. Eur Heart J 28 (2007) 829-835
25. Braunwald E. Biomarkers in heart failure. N Engl J Med 358 (2008) 2148-2159
26. Kanda H., Kita Y., Okamura T., Kadowaki T., Yoshida Y., Nakamura Y., and Ueshima H. What factors are associated with high plasma B-type natriuretic peptide levels in a general Japanese population?. J Hum Hypertens 19 (2005) 165-172
27. Najjar S.S., Scuteri A., Shetty V., Wright J.G., Muller D.C., Fleg J.L., Spurgeon H.P., Ferrucci L., and Lakatta E.G. Pulse wave velocity is an independent predictor of the longitudinal increase in systolic blood pressure and of incident hypertension in the Baltimore Longitudinal Study of Aging. J Am Coll Cardiol 51 (2008) 1377-1383
28. Trippodo N.C., Yamamoto J., and Frolich E.D. Whole-body venous capacity and effective total tissue compliance in SHR. Hypertension 3 (1981) 104-112
29. Keating G.M., and Goa K.L. Nesiritide: a review of its use in acute decompensated heart failure. Drugs 63 (2003) 47-70
30. Yu W.C., Chuang S.Y., Lin Y.P., and Chen C.H. Brachial-ankle vs carotid-femoral pulse wave velocity as a determinant of cardiovascular structure and function. J Hum Hypertens 22 (2008) 24-31